<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01556126</url>
  </required_header>
  <id_info>
    <org_study_id>C21102</org_study_id>
    <nct_id>NCT01556126</nct_id>
  </id_info>
  <brief_title>Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population</brief_title>
  <acronym>PARTICIPATE</acronym>
  <official_title>Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CID - Carbostent &amp; Implantable Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CID - Carbostent &amp; Implantable Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate safety and efficacy performances of CRE8 Drug Eluting
      Stent, in patients comparable to the everyday's clinical practice population, with a specific
      focus on diabetics, that will be part of a pre-specified study subgroup.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical composite endpoint: Cardiac death/Target vessel MI/Clinically indicated TLR</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical composite endpoints: - Cardiac death/Target vessel MI/Clinically indicated TLR - All death/All MI/All Repeat Revascularization</measure>
    <time_frame>At 30 days, 1 year and yearly up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>within 24 hours, 1 month, 6 months, 1 year and yearly up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic in-stent and in-segment endpoints (in the first 100 patients included in the pre-specified diabetic subgroup).</measure>
    <time_frame>At 6 months</time_frame>
    <description>reference vessel diameter; minimal lumen diameter; % diameter stenosis; binary restenosis; late lumen loss</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Stable Angina</condition>
  <condition>Unstable Angina</condition>
  <condition>Acute Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Amphilimus Eluting Stent (CRE8)</intervention_name>
    <description>Sirolimus formulated coronary eluting stent</description>
    <other_name>CRE8</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years;

          -  Patients with symptoms of stable angina or documented silent ischemia;

          -  Patient with coronary artery disease ranging between 0 and 22 according to the Syntax
             score;

          -  Patients with acute coronary syndrome, including unstable angina, NSTEMI and STEMI;

          -  Patient is eligible for percutaneous coronary intervention (PCI) and is an acceptable
             candidate for surgical revascularization (CABG);

          -  Left ventricular ejection fraction &gt; 30%;

          -  Target de-novo lesions with diameter stenosis &gt; 50% (including total occlusion);

          -  Target lesion located in a target vessel with a diameter ranging from 2.5 to 4.0 mm;

          -  Patient has been informed of the nature of the study and agrees to its provisions and
             has provided written informed consent as approved by the Ethical Committee of the
             respective clinical site.

        Exclusion Criteria:

          -  Female with childbearing potential or lactating;

          -  Known allergies to antiplatelets, anticoagulants, contrast media, sirolimus or cobalt
             chromium;

          -  Acute or chronic renal dysfunction (defined as creatinine greater than 2.5 mg/dl or on
             dialysis);

          -  Thrombocytopenia (platelet count less than 100,000/mm³) or hypercoagulable disorder;

          -  Known significant gastro-intestinal or urinary bleeding within the past 6 months;

          -  Patient refusing blood transfusion;

          -  Patient currently under immunosuppressant therapy;

          -  Patient with planned surgery within 6 months from the index procedure unless dual
             antiplatelet therapy is maintained throughout the peri-surgical period;

          -  Co-morbidities that could interfere with completion of study procedures, or life
             expectancy less than 1 year;

          -  Participating in another investigational drug or device trial that has not completed
             the primary endpoint or would interfere with the endpoints of this study;

          -  Patient underwent target vessel revascularization with a DES within 3 months prior to
             the index procedure;

          -  Target lesion is located or supplied by an arterial or venous bypass graft.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Colombo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione San Raffaele del Monte Tabor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Oost Limburg</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda USL 8 Arezzo - Ospedale San Donato</name>
      <address>
        <city>Arezzo</city>
        <state>AR</state>
        <zip>52100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.S.L. CN1 - Ospedale SS Annunziata di Savigliano</name>
      <address>
        <city>Savigliano</city>
        <state>CN</state>
        <zip>12038</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Città Studi</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione San Raffaele del Monte Tabor</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas IRCCS</name>
      <address>
        <city>Rozzano</city>
        <state>MI</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda di Rilievo Nazionale e di Alta Specializzazione - Presidio Ospedaliero &quot;Civico e Benfratelli&quot;</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <state>PD</state>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Salvatore</name>
      <address>
        <city>Pesaro</city>
        <state>PU</state>
        <zip>61100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Policlinico Umberto I</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Sanitaria Locale n°2 Savonese - Ospedale San Paolo</name>
      <address>
        <city>Savona</city>
        <state>SV</state>
        <zip>17100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASL TO2 Torino Nord - Ospedale S. Giovanni Bosco</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10154</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Mediterranea SpA</name>
      <address>
        <city>Napoli</city>
        <zip>80122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria &quot;Federico II&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <zip>1091 AC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TweeSteden Ziekenhuis</name>
      <address>
        <city>Tilburg</city>
        <zip>5042 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital - Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0027</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Kardiologii SPSK4 w Lublinie</name>
      <address>
        <city>Lublin</city>
        <zip>20-954</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny Przemienienia Panskiego</name>
      <address>
        <city>Poznan</city>
        <zip>61-848</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Poland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2012</study_first_submitted>
  <study_first_submitted_qc>March 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2012</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary artery disease</keyword>
  <keyword>Drug Eluting Stent</keyword>
  <keyword>All comers patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

